Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 298
Filtrar
1.
Plant Cell Physiol ; 63(5): 649-657, 2022 May 16.
Artículo en Inglés | MEDLINE | ID: mdl-35238923

RESUMEN

Flowering time is an agriculturally important trait that can be manipulated by various approaches such as breeding, growth control and genetic modifications. Despite its potential advantages, including fine-tuning the regulation of flowering time, few reports have explored the use of chemical compounds to manipulate flowering. Here, we report that sulfanilamide, an inhibitor of folate biosynthesis, delays flowering by repressing the expression of florigen FLOWERING LOCUS T (FT) in Arabidopsis thaliana. Transcriptome deep sequencing and quantitative polymerase chain reaction analyses showed that the expression of the circadian clock gene LUX ARRYTHMO/PHYTOCLOCK1 (LUX/PCL1) is altered by sulfanilamide treatment. Furthermore, in the lux nox mutant harboring loss of function in both LUX and its homolog BROTHER OF LUX ARRHYTHMO (BOA, also named NOX), the inhibitory effect of sulfanilamide treatment on FT expression was weak and the flowering time was similar to that of the wild type, suggesting that the circadian clock may contribute to the FT-mediated regulation of flowering by sulfanilamide. Sulfanilamide also delayed flowering time in arugula (Eruca sativa), suggesting that it is involved in the regulation of flowering across Brassicaceae. We propose that sulfanilamide is a novel modulator of flowering.


Asunto(s)
Proteínas de Arabidopsis , Arabidopsis , Relojes Circadianos , Arabidopsis/metabolismo , Proteínas de Arabidopsis/genética , Proteínas de Arabidopsis/metabolismo , Relojes Circadianos/genética , Ritmo Circadiano/genética , Flores , Regulación de la Expresión Génica de las Plantas , Fotoperiodo , Fitomejoramiento , Sulfanilamidas/metabolismo , Factores de Transcripción/metabolismo
2.
Sci Rep ; 7(1): 16901, 2017 12 04.
Artículo en Inglés | MEDLINE | ID: mdl-29203791

RESUMEN

Metabolic diseases are characterized by a decreased action of insulin. During the course of the disease, usual treatments frequently fail and patients are finally submitted to insulinotherapy. There is thus a need for innovative therapeutic strategies to improve insulin action. Growth factor receptor-bound protein 14 (Grb14) is a molecular adapter that specifically binds to the activated insulin receptor (IR) and inhibits its tyrosine kinase activity. Molecules disrupting Grb14-IR binding are therefore potential insulin-sensitizing agents. We used Structure-Based Virtual Ligand Screening to generate a list of 1000 molecules predicted to hinder Grb14-IR binding. Using an acellular bioluminescence resonance energy transfer (BRET) assay, we identified, out of these 1000 molecules, 3 compounds that inhibited Grb14-IR interaction. Their inhibitory effect on insulin-induced Grb14-IR interaction was confirmed in co-immunoprecipitation experiments. The more efficient molecule (C8) was further characterized. C8 increased downstream Ras-Raf and PI3-kinase insulin signaling, as shown by BRET experiments in living cells. Moreover, C8 regulated the expression of insulin target genes in mouse primary hepatocytes. These results indicate that C8, by reducing Grb14-IR interaction, increases insulin signalling. The use of C8 as a lead compound should allow for the development of new molecules of potential therapeutic interest for the treatment of diabetes.


Asunto(s)
Proteínas Adaptadoras Transductoras de Señales/metabolismo , Receptor de Insulina/metabolismo , Sulfanilamidas/química , Proteínas Adaptadoras Transductoras de Señales/química , Sitios de Unión , Supervivencia Celular/efectos de los fármacos , Transferencia Resonante de Energía de Fluorescencia , Células HEK293 , Humanos , Insulina/metabolismo , Simulación del Acoplamiento Molecular , Fosfatidilinositol 3-Quinasas/metabolismo , Fosforilación , Unión Proteica , Estructura Terciaria de Proteína , Receptor de Insulina/química , Transducción de Señal/efectos de los fármacos , Sulfanilamidas/metabolismo , Sulfanilamidas/farmacología
3.
J Hazard Mater ; 318: 407-416, 2016 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-27450332

RESUMEN

Sulfonamides (SAs) are extensively used antibiotics and their residues in the water bodies propose potential threat to the public. In this study, degradation efficiency of sulfanilamide (SAM), which is the precursor of SAs, using WO3 nanoplates and their Ag heterogeneous as photocatalysts was investigated. WO3 nanoplates with uniform size were synthesized by a facile one step hydrothermal method. Different amount of Ag nanoparticles (Ag NPs) were loaded onto WO3 nanoplates using a photo-reduction method to generate WO3/Ag composites. The physio-chemical properties of synthesized nanomaterials were systematically characterized. Photodegradation of SAM by WO3 and WO3/Ag composites was conducted under visible light irradiation. The results show that WO3/Ag composites performed much better than pure WO3 where the highest removal rate was 96.2% in 5h. Ag as excellent antibacterial agent also endows certain antibacterial efficiency to WO3, and 100% removal efficiency against Escherichia Coli and Bacillus subtilis could be achieved in 2h under visible light irradiation for all three WO3/Ag composites synthesized. The improved performance in terms of SAM degradation and antibacterial activity of WO3/Ag can be attributed to the improved electron-hole pair separation rate where Ag NPs act as effective electron trapper during the photocatalytic process.


Asunto(s)
Antibacterianos/metabolismo , Bacterias/efectos de los fármacos , Bacterias/efectos de la radiación , Óxidos/química , Plata/química , Sulfanilamidas/química , Sulfanilamidas/metabolismo , Tungsteno/química , Bacillus subtilis/efectos de los fármacos , Biodegradación Ambiental , Catálisis , Escherichia coli/efectos de los fármacos , Concentración de Iones de Hidrógeno , Luz , Nanoestructuras , Procesos Fotoquímicos , Fotólisis , Sulfanilamida , Sulfanilamidas/efectos de la radiación , Temperatura
4.
J Hazard Mater ; 313: 147-58, 2016 08 05.
Artículo en Inglés | MEDLINE | ID: mdl-27060864

RESUMEN

The aim of our study was to assess the aerobic biodegradation of four selected sulfonamides (sulfanilamide, sulfamethoxazole, sulfadiazine and sulfathiazole) using water samples drawn from highly polluted rivers. Additionally, we aimed to identify the factors that have a significant effect on the process efficiency. The 19 water samples were collected from Brynica and Czarna Przemsza rivers (in Poland) at the same location at approximately monthly intervals. A characteristic feature of the results is the presence of significant differences between the rates of sulfonamides biodegradation in particular samples. The sulfonamide most resistant to biodegradation was sulfamethoxazole, whereas sulfathiazole was most biodegradable. Seasonal variations and related microbial population changes had the most significant effects on sulfonamides biodegradation, e.g., the studied process was highly inhibited during wintertime. A decrease in the biodegradation rate in the river water could be caused by an accidental water pollution by industrial wastewater with heavy metals, an increase in salinity and a decrease in pH, and turbidity.


Asunto(s)
Antibacterianos/metabolismo , Ríos/química , Sulfanilamidas/metabolismo , Contaminantes Químicos del Agua/metabolismo , Monitoreo del Ambiente , Concentración de Iones de Hidrógeno , Polonia , Salinidad , Estaciones del Año , Microbiología del Agua
5.
J AOAC Int ; 99(2): 571-8, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26997479

RESUMEN

A sensitive and highly selective stability-indicating gradient HPLC method was developed and validated for simultaneous determination of clorsulon (CLO) and ivermectin (IVM) in the presence of their degradation products. The drugs were subjected to different stress conditions, including acid and alkaline hydrolysis, oxidative, thermal, and photolytic forced degradation. The robustness of the proposed method was assessed using the Plackett-Burman experimental design, the factors affecting system performance were defined, and nonsignificant intervals for the significant factors were determined. The separation was carried out on a ZORBAX SB phenyl analytical column (250 × 4.6 mm id, 5 µm particle size), with gradient elution utilizing 10 mM sodium dihydrogen phosphate and acetonitrile as mobile phase. UV detection was performed for CLO and IVM at 254 nm over a concentration range of 4-140 and 5-50 µg/mL, respectively, with mean percentage recoveries of 99.90 ± 1.30 and 98.59 ± 1.16%, respectively. The proposed method was successfully applied to a pharmaceutical dosage form containing the investigated drugs. The results were statistically compared with the official HPLC methods, and no significant differences were found.


Asunto(s)
Ivermectina/análisis , Sulfanilamidas/análisis , Cromatografía Líquida de Alta Presión , Diseño de Equipo , Ivermectina/metabolismo , Sulfanilamidas/metabolismo , Rayos Ultravioleta
6.
Bioorg Med Chem Lett ; 26(4): 1253-9, 2016 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-26832216

RESUMEN

The Antarctic bacterium Colwellia psychrerythraea encodes for a γ-class carbonic anhydrase (CA, EC 4.2.1.1), which was cloned, purified and characterized. The enzyme (CpsCAγ) has a moderate catalytic activity for the physiologic reaction of CO2 hydration to bicarbonate and protons, with a k(cat) 6.0×10(5) s(-1) and a k(cat)/K(m) of 4.7×10(6) M(-1) s(-1). A series of sulfonamides and a sulfamate were investigated as inhibitors of the new enzyme. The best inhibitor was metanilamide (K(I) of 83.5 nM) followed by indisulam, valdecoxib, celecoxib, sulthiame and hydrochlorothiazide (K(I)s ranging between 343 and 491 nM). Acetazolamide, methazolamide as well as other aromatic/heterocyclic derivatives showed inhibition constants between 502 and 7660 nM. The present study may shed some more light regarding the role that γ-CAs play in the life cycle of psychrophilic bacteria as the Antarctic one investigated here, by allowing the identification of inhibitors which may be useful as pharmacologic tools.


Asunto(s)
Alteromonadaceae/enzimología , Antibacterianos/química , Proteínas Bacterianas/antagonistas & inhibidores , Inhibidores de Anhidrasa Carbónica/química , Anhidrasas Carbónicas/química , Sulfanilamidas/química , Antibacterianos/metabolismo , Proteínas Bacterianas/clasificación , Proteínas Bacterianas/metabolismo , Inhibidores de Anhidrasa Carbónica/metabolismo , Anhidrasas Carbónicas/clasificación , Anhidrasas Carbónicas/metabolismo , Humanos , Cinética , Filogenia , Unión Proteica , Sulfanilamida , Sulfanilamidas/metabolismo
7.
J Vet Med Sci ; 77(12): 1555-63, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26212255

RESUMEN

Diaveridine (DVD) is used in combination with sulphachloropyrazine (SPZ) as an effective antibacterial agent and antiprotozoal agent, respectively, in humans and animals. To gain a better understanding of the metabolism of SPZ and DVD in the food-producing animals, a high performance liquid chromatography (HPLC) method to determine and quantify sulphachloropyrazine (SPZ) and diaveridine (DVD) suspension residues from broilers is reported. Thirty healthy chickens were orally administered with sulphachloropyrazine-diaveridine (SPZ-DVD) suspension in water of 300 mg/l (SPZ) per day for seven successive days. Six chickens per day were slaughtered at 0, 1, 3, 5 and 7 days after the last administration. This procedure permitted SPZ and DVD to be separated from muscle tissue, liver, kidneys and skin with fat after extraction with acetonitrile and acetone under slightly acidic conditions. From the detected residuals in different tissues, we found that SPZ was quickly eliminated in liver and muscle, and slowly eliminated in kidney and skin with fat. DVD was quickly eliminated in liver and slowly eliminated in kidney. The withdrawal period of SPZ was 3.26, 3.72, 4.39 and 5.43 days in muscle, liver, kidney and skin with fat, respectively. The withdrawal period of DVD was 4.77, 4.94, 6.74 and 4.58 days in muscle, liver, kidney and skin with fat, respectively. Therefore, the suggested withdrawal period for SPZ-DVD suspension should be 7 days after dosing for seven successive days.


Asunto(s)
Cromatografía Líquida de Alta Presión/veterinaria , Residuos de Medicamentos , Carne/análisis , Pirimidinas/química , Sulfanilamidas/química , Administración Oral , Animales , Antiinfecciosos/administración & dosificación , Antiinfecciosos/química , Antiinfecciosos/metabolismo , Antiinfecciosos/farmacocinética , Pollos , Femenino , Riñón/química , Riñón/metabolismo , Hígado/química , Hígado/metabolismo , Masculino , Músculo Esquelético/química , Músculo Esquelético/metabolismo , Pirimidinas/administración & dosificación , Pirimidinas/metabolismo , Pirimidinas/farmacocinética , Piel/química , Piel/metabolismo , Grasa Subcutánea/química , Grasa Subcutánea/metabolismo , Sulfanilamidas/administración & dosificación , Sulfanilamidas/metabolismo , Sulfanilamidas/farmacocinética
8.
Appl Microbiol Biotechnol ; 100(5): 2439-47, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26563551

RESUMEN

Sulfonamide antibiotics are commonly detected in the environment. Microbial degradation can play an important role in the dissipation of sulfonamide antibiotics. However, many aspects regarding the influential factor and biodegradation pathway remain essentially unclear. Moreover, phylogenetic information on the sulfonamide-degrading microbial community is still very limited. The present study investigated the biodegradation of sulfonamide antibiotic sulfanilamide by acclimated mixed culture and its influential factors, and the sulfanilamide-degrading microbial community. At the initial sulfanilamide concentration of 100 µg/L, nearly half of the antibiotic could be removed by acclimated microbial populations after 1 week of incubation, and an average removal rate of 78.3 % could be achieved in 4 weeks. p-Phenylenediamine, benzene sulfonamide, and hydroxylamine benzene sulfonamide were identified as the potential intermediates. Sulfanilamide biodegradation could be enhanced by a temperature rise and the presence of external carbon or nitrogen sources. The richness, diversity, and structure of the bacterial community showed a remarkable change with sulfanilamide biodegradation. Firmicutes and Bacteroidetes (mainly represented by classes Bacilli and Flavobacteriia) dominated the sulfanilamide-degrading bacterial community.


Asunto(s)
Antiinfecciosos/metabolismo , Bacterias/metabolismo , Biodiversidad , Contaminantes Ambientales/metabolismo , Sulfanilamidas/metabolismo , Bacterias/clasificación , Bacterias/crecimiento & desarrollo , Bacterias/aislamiento & purificación , Biotransformación , Sulfanilamida
9.
Future Med Chem ; 7(9): 1173-96, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26132525

RESUMEN

Caspases-3 and -7 play an essential role in apoptosis. Isatin sulfonamides have been identified as potent inhibitors of these executing caspases. Besides pharmacological application, these compounds can also serve as recognition units to target caspases using positron emission tomography (PET) and single-photon emission computed tomography (SPECT) when labeled with a positron or a gamma emitter. Fluorinated, alkylated, arylated isatin derivatives, in addition to derivatives modified with heterocycles, have been prepared in order to improve their binding potency, selectivity and metabolic stability. Structural optimization has led to stable, highly active inhibitors, which after labeling have been applied in PET studies in tumor mouse models and for first preclinical and clinical investigations with healthy human volunteers. The results support further development of such radiotracers for clinical apoptosis imaging.


Asunto(s)
Caspasa 3/química , Caspasa 7/química , Inhibidores de Caspasas/química , Isatina/análogos & derivados , Sulfanilamidas/química , Animales , Apoptosis/efectos de los fármacos , Caspasa 3/metabolismo , Caspasa 7/metabolismo , Inhibidores de Caspasas/metabolismo , Inhibidores de Caspasas/farmacología , Humanos , Neoplasias/diagnóstico por imagen , Neoplasias/patología , Tomografía de Emisión de Positrones , Unión Proteica , Radiografía , Relación Estructura-Actividad , Sulfanilamida , Sulfanilamidas/metabolismo , Sulfanilamidas/farmacología , Tomografía Computarizada de Emisión de Fotón Único
10.
Spectrochim Acta A Mol Biomol Spectrosc ; 144: 183-91, 2015 Jun 05.
Artículo en Inglés | MEDLINE | ID: mdl-25754395

RESUMEN

Interaction between sulfanilamide (SAM) and sulfamethoxazole (SMO) with BSA and DNA base (adenine) was investigated by UV-visible, fluorescence, cyclic voltammetry and molecular docking studies. Stern-Volmer fluorescence quenching constant (Ka) suggests SMO is more quenched with BSA/adenine than that of SAM. The distance r between donor (BSA/adenine) and acceptor (SAM and SMO) was obtained according to fluorescence resonance energy transfer (FRET). The results showed that hydrophobic forces, electrostatic interactions, and hydrogen bonds played vital roles in the SAM and SMO with BSA/adenine binding interaction. During the interaction, sulfa drugs could insert into the hydrophobic pocket, where the non-radioactive energy transfer from BSA/adenine to sulfa drugs occurred with high possibility. Cyclic voltammetry results suggested that when the drug concentration is increased, the anodic electrode potential deceased. The docking method indicates aniline group is interacted with the BSA molecules.


Asunto(s)
Adenina/metabolismo , Simulación del Acoplamiento Molecular , Albúmina Sérica Bovina/metabolismo , Sulfametoxazol/metabolismo , Sulfanilamidas/metabolismo , Adenina/química , Animales , Sitios de Unión , Bovinos , Técnicas Electroquímicas , Transferencia de Energía , Enlace de Hidrógeno , Cinética , Conformación Molecular , Espectrometría de Fluorescencia , Espectrofotometría Ultravioleta , Electricidad Estática , Sulfametoxazol/química , Sulfanilamida , Sulfanilamidas/química
11.
Biotech Histochem ; 90(1): 45-54, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25151989

RESUMEN

We investigated the applicability of catechin-specific-reagent (CSR) for histochemical evaluation of catechins. The diazotized arylamine moiety in CSR reacts specifically with the A-ring of catechins to yield a golden yellow complex. This makes it highly specific for spectrophotometric quantification of catechins. Therefore, microtome cut sections of untransformed and osmotin-expressing transgenic leaves and stem of tea were stained with CSR. We found catechins in the form of golden yellow globules. The catechin globules increased in the structurally intact and highly turgid cells of osmotin expressing transgenic tea plants after stress treatment with 20% PEG; by contrast, the cells in non-transgenic plants accumulated fewer catechin globules. Spectrophotometric quantification of catechins also confirmed higher levels in transgenics compared to untransformed plants. We found elevated accumulation of catechins in stress tolerant cells of tea leaves.


Asunto(s)
Catequina/metabolismo , Polietilenos/farmacología , Sulfanilamidas/metabolismo , Té/metabolismo , Cromatografía Líquida de Alta Presión/métodos , Hojas de la Planta/efectos de los fármacos , Hojas de la Planta/genética , Hojas de la Planta/metabolismo , Plantas Modificadas Genéticamente , Espectrofotometría/métodos , Estrés Fisiológico/fisiología , Sulfanilamida , Té/efectos de los fármacos
12.
Bioorg Med Chem ; 22(24): 6768-75, 2014 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-25468040

RESUMEN

Reaction of γ-Boc-GABA, prepared by protecting the γ-amino moiety of the amino butyric acid with the tert-butyloxycarbonyl (Boc) protecting group, with 4-methyl/ethyl benzenesulfonamide, followed by removal of the Boc protecting group in 3 M HCl afforded the corresponding hydrochlorides, which were further derivatized by reaction with a varying of aryl isocyanates to give a new classes of ureido substituted benzenesulfonamide containing a GABA moiety. Inhibition studies of the human carbonic anhydrase(CA, EC 4.2.1.1) isoforms, CA I­XIV with these new compounds revealed that they possess moderate-weak inhibition potency against hCA III, IV, VA, VI and XIII, rather efficient inhibitory power against hCA I, VI, and IX, and excellent inhibition of the physiologically relevant hCA II and VII, as well as of the two tumor-associated isoforms CA IX and XII. The inhibition profile of the new ureido-substituted benzenesulfonamides reported here is thus very different from the corresponding ureido-substituted analogs incorporating sulfanilamide, which were previously investigated as inhibitors of some of these enzymes.


Asunto(s)
Inhibidores de Anhidrasa Carbónica/química , Anhidrasas Carbónicas/metabolismo , Sulfanilamidas/química , Ácido gamma-Aminobutírico/química , Inhibidores de Anhidrasa Carbónica/síntesis química , Inhibidores de Anhidrasa Carbónica/metabolismo , Anhidrasas Carbónicas/química , Anhidrasas Carbónicas/genética , Humanos , Isoenzimas/antagonistas & inhibidores , Isoenzimas/genética , Isoenzimas/metabolismo , Unión Proteica , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Relación Estructura-Actividad , Sulfanilamida , Sulfanilamidas/síntesis química , Sulfanilamidas/metabolismo
13.
Bioorg Med Chem ; 21(6): 1522-5, 2013 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-22974493

RESUMEN

Carbonic anhydrase (CA, EC: 4.2.1.1) was purified from sheep kidney by affinity chromatography on a Sepharose 4B-tyrosine-sulfanilamide column. By means of two consecutive procedures, the enzyme (sCA) was purified 227.61-fold with a yield of 60.75%, and a specific activity of 838.89U/mg proteins. The optimum temperature, ionic strength and pH were determined to be 35°C, 20mM and 8.5, respectively. The molecular weight determined by SDS-PAGE was found to be 29kDa. The kinetic parameters, KM and Vmax values were determined for the 4-nitrophenyl acetate (p-NpA) hydrolysis reaction. Some sulfonamides were tested as inhibitors against the purified CAs enzyme. The Ki constants for benzenesulfonamide (1), sulfanilamide (2), mafenide (3), 4-(2-aminoethyl) benzenesulfonamide (4), 4-methyl-benzenesulfonamide (5), 2-bromo-benzenesulfonamide (6), naphthalene-2-sulfonamide (7), 4-amino-6-chlorobenzene-1,3-disulfonamide (8) and saccharin (9) were in the range 1.348-69.31µM.


Asunto(s)
Inhibidores de Anhidrasa Carbónica/química , Anhidrasas Carbónicas/química , Riñón/enzimología , Sulfanilamidas/química , Animales , Inhibidores de Anhidrasa Carbónica/metabolismo , Anhidrasas Carbónicas/aislamiento & purificación , Anhidrasas Carbónicas/metabolismo , Concentración de Iones de Hidrógeno , Cinética , Concentración Osmolar , Unión Proteica , Ovinos , Sulfanilamida , Sulfanilamidas/metabolismo , Temperatura
14.
Indian J Med Res ; 134: 419-31, 2011 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22089602

RESUMEN

Among the aetiological agents of treatable sexually transmitted diseases (STDs), Neissseria gonorrhoeae is considered to be most important because of emerging antibiotic resistant strains that compromise the effectiveness of treatment of the disease - gonorrhoea. In most of the developing countries, treatment of gonorrhoea relies mainly on syndromic management rather than the aetiological based therapy. Gonococcal infections are usually treated with single-dose therapy with an agent found to cure > 95 per cent of cases. Unfortunately during the last few decades, N. gonorrhoeae has developed resistance not only to less expensive antimicrobials such as sulphonamides, penicillin and tetracyclines but also to fluoroquinolones. The resistance trend of N. gonorrhoeae towards these antimicrobials can be categorised into pre-quinolone, quinolone and post-quinolone era. Among the antimicrobials available so far, only the third-generation cephalosporins could be safely recommended as first-line therapy for gonorrhoea globally. However, resistance to oral third-generation cephalosporins has also started emerging in some countries. Therefore, it has become imperative to initiate sustained national and international efforts to reduce infection and misuse of antibiotics so as to prevent further emergence and spread of antimicrobial resistance. It is necessary not only to monitor drug resistance and optimise treatment regimens, but also to gain insight into how gonococcus develops drug resistance. Knowledge of mechanism of resistance would help us to devise methods to prevent the occurrence of drug resistance against existing and new drugs. Such studies could also help in finding out new drug targets in N. gonorrhoeae and also a possibility of identification of new drugs for treating gonorrhoea.


Asunto(s)
Antibacterianos/uso terapéutico , Farmacorresistencia Bacteriana/genética , Gonorrea/tratamiento farmacológico , Neisseria gonorrhoeae/efectos de los fármacos , Neisseria gonorrhoeae/genética , Quinolonas/uso terapéutico , Cefalosporinas/metabolismo , Cefalosporinas/uso terapéutico , Gonorrea/epidemiología , Humanos , Quinolonas/metabolismo , Sulfanilamidas/metabolismo , Sulfanilamidas/uso terapéutico
15.
Electrophoresis ; 31(22): 3691-5, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-20972990

RESUMEN

Back-scattering interferometry (BSI) is a label-free, free-solution, small-volume technique used for characterizing binding interactions, which is also relevant to a growing number of biosensing applications including drug discovery. Here, we use BSI to characterize the interaction of carbonic anhydrase enzyme II with five well-known carbonic anhydrase enzyme II inhibitors (± sulpiride, sulfanilamide, benzene sulfonamide, dansylamide, and acetazolamide) in the presence of DMSO. Dissociation constants calculated for each interaction were consistent with literature values previously obtained using surface plasmon resonance and fluorescence-based competition assays. Results demonstrate the potential of BSI as a drug-screening tool which is fully compatible with DMSO and does not require immobilization or labeling, therefore allowing binding interactions to be characterized in the native state. BSI has the potential for reducing labor costs, sample consumption, and assay time while providing enhanced reliability over existing techniques.


Asunto(s)
Técnicas Biosensibles/métodos , Inhibidores de Anhidrasa Carbónica/química , Inhibidores de Anhidrasa Carbónica/farmacología , Anhidrasas Carbónicas/química , Interferometría/métodos , Acetazolamida/química , Acetazolamida/metabolismo , Anhidrasas Carbónicas/metabolismo , Compuestos de Dansilo/química , Compuestos de Dansilo/metabolismo , Dimetilsulfóxido/química , Unión Proteica , Dispersión de Radiación , Sulfanilamidas/química , Sulfanilamidas/metabolismo
16.
Chem Res Toxicol ; 23(1): 184-92, 2010 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19954178

RESUMEN

Exposure to sulfamethoxazole (SMX) is associated with T-cell-mediated hypersensitivity reactions in human patients. T-cells can be stimulated by the putative metabolite nitroso SMX, which binds irreversibly to protein. The hydroxylamine and nitroso derivatives of three arylamine benzenesulfonamides, namely, sulfamethozaxole, sulfadiazine, and sulfapyridine, were synthesized, and their T-cell stimulatory capacity in the mouse was explored. Nitroso derivatives were synthesized by a three-step procedure involving the formation of nitro and hydroxylamine sulfonamide intermediates. For immune activation, female Balb-c strain mice were administered nitroso sulfonamides four times weekly for 2 weeks. After 14 days, isolated splenocytes were incubated with the parent compounds, hydroxylamine metabolites, and nitroso derivatives to measure antigen-specific proliferation. To explore the requirement of irreversible protein binding for spleen cell activation, splenocytes were incubated with nitroso derivatives in the presence or absence of glutathione. Splenocytes from nitroso sulfonamide-sensitized mice proliferated and secreted interleukin (IL)-2, IL-4, IL-5, and granulocyte monocyte colony-stimulating factor following stimulation with nitroso derivatives but not the parent compounds. Splenocytes from sensitized mice were also stimulated to proliferate with hydroxylamine and nitroso derivatives of the structurally related sulfonamides. The addition of glutathione inhibited the nitroso-specific T-cell response. Hydroxylamine metabolites were unstable in aqueous solution: Spontaneous transformation yielded appreciable amounts of nitroso and azoxy compounds as well as the parent compounds within 0.1 h. T-cell cross-reactivity with nitroso sulfonamides provides a mechanistic explanation as to why structurally related arylamine benzenesulfonamides are contraindicated in hypersensitive patients.


Asunto(s)
Antiinfecciosos/inmunología , Hidroxilamina/metabolismo , Compuestos Nitrosos/inmunología , Sulfanilamidas/inmunología , Linfocitos T/inmunología , Animales , Antiinfecciosos/química , Antiinfecciosos/metabolismo , Proliferación Celular , Células Cultivadas , Femenino , Factor Estimulante de Colonias de Granulocitos y Macrófagos/metabolismo , Humanos , Hidroxilamina/química , Interleucina-2/metabolismo , Interleucina-4/metabolismo , Interleucina-5/metabolismo , Activación de Linfocitos , Ratones , Ratones Endogámicos BALB C , Compuestos Nitrosos/química , Compuestos Nitrosos/metabolismo , Sulfametoxazol/análogos & derivados , Sulfametoxazol/inmunología , Sulfametoxazol/metabolismo , Sulfanilamidas/química , Sulfanilamidas/metabolismo
17.
Int J Pharm ; 381(2): 199-204, 2009 Nov 03.
Artículo en Inglés | MEDLINE | ID: mdl-19782883

RESUMEN

Intestinal efflux transporters can significantly reduce the absorption of the drug after peroral application. In this work we studied secretion of glutathione conjugates triggered by glucose at the luminal side of the intestine. Glucose stimulated secretion of DNPSG, NEMSG and CDNB. We used some different monosaccharides and determined that glucose, galactose and alpha-methylglucopyranoside trigger the secretion, while mannitol and fructose do not. We concluded that interaction with SGLT transporter is the key process necessary for this triggering. To determine which of possible glutathione conjugate transporters (MRP2, MRP4, BCRP or RLIP76) is responsible for the secretion of glutathione conjugates, we used benzbromarone, a MRP inhibitor, and sulfanitran and furosemide, two allosteric MRP2 activators. Benzbromarone inhibited glucose stimulated DNPSG secretion, while allosteric activators additionally increased the secretion. We concluded that MRP2 transporter is related to glucose stimulated DNPSG secretion. Regarding the work of Kubitz et al. we tested the effect of changed medium osmolarity on DNPSG transport and determined that hypoosmolar conditions trigger secretion of DNPSG. These findings suggest that intestinal MRP2 activity has no basal level, but can be stimulated by hypoosmolarity and SGLT transport.


Asunto(s)
Glutatión/análogos & derivados , Intestino Delgado/metabolismo , Monosacáridos/metabolismo , Vías Secretoras/fisiología , Transportadoras de Casetes de Unión a ATP/agonistas , Transportadoras de Casetes de Unión a ATP/antagonistas & inhibidores , Animales , Benzbromarona/metabolismo , Polaridad Celular , Dinitroclorobenceno/metabolismo , Enterocitos/metabolismo , Furosemida/metabolismo , Glucosa/administración & dosificación , Glucosa/metabolismo , Glutatión/química , Glutatión/metabolismo , Glutatión Transferasa/metabolismo , Técnicas In Vitro , Masculino , Moduladores del Transporte de Membrana/metabolismo , Proteínas de Transporte de Membrana/metabolismo , Metilglucósidos/administración & dosificación , Metilglucósidos/metabolismo , Monosacáridos/administración & dosificación , Proteínas Asociadas a Resistencia a Múltiples Medicamentos/agonistas , Proteínas Asociadas a Resistencia a Múltiples Medicamentos/antagonistas & inhibidores , Concentración Osmolar , Permeabilidad , Ratas , Ratas Wistar , Vías Secretoras/efectos de los fármacos , Proteínas de Transporte de Sodio-Glucosa/metabolismo , Succinimidas/metabolismo , Sulfanilamidas/metabolismo
18.
J Bacteriol ; 191(14): 4562-71, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19429622

RESUMEN

LeuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression. Using genomic screening by systematic evolution of ligands by exponential enrichment (SELEX) in vitro, a total of 106 DNA sequences were isolated from 12 different regions of the Escherichia coli genome. All of the SELEX fragments formed complexes in vitro with purified LeuO. After Northern blot analysis of the putative target genes located downstream of the respective LeuO-binding sequence, a total of nine genes were found to be activated by LeuO, while three genes were repressed by LeuO. The LeuO target gene collection included several multidrug resistance genes. A phenotype microarray assay was conducted to identify the gene(s) responsible for drug resistance and the drug species that are under the control of the LeuO target gene(s). The results described herein indicate that the yjcRQP operon, one of the LeuO targets, is involved in sensitivity control against sulfa drugs. We propose to rename the yjcRQP genes the sdsRQP genes (sulfa drug sensitivity determinant).


Asunto(s)
Antiinfecciosos/metabolismo , Farmacorresistencia Bacteriana , Proteínas de Escherichia coli/fisiología , Escherichia coli/efectos de los fármacos , Escherichia coli/fisiología , Regulación Bacteriana de la Expresión Génica , Sulfanilamidas/metabolismo , Factores de Transcripción/fisiología , Transporte Biológico , Perfilación de la Expresión Génica , Proteínas de Transporte de Membrana/metabolismo , Técnica SELEX de Producción de Aptámeros
19.
Anal Biochem ; 390(1): 74-8, 2009 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-19362065

RESUMEN

Nitric oxide synthase (NOS) inhibitors are potential drug candidates because it has been well demonstrated that excessive production of nitric oxide critically contributes to a range of diseases. Most inhibitors have been screened in vitro using recombinant enzymes, leading to the discovery of a variety of potent compounds. To make inhibition studies more physiologically relevant and bridge the gap between the in vitro assay and in vivo studies, we report here a cellular model for screening NOS inhibitors. Stable transformants were generated by overexpressing rat neuronal NOS in HEK 293T cells. The enzyme was activated by introducing calcium ions into cells, and its activity was assayed by determining the amount of nitrite that was formed in culture medium using the Griess reagent. We tested a few NOS inhibitors with this assay and found that the method is sensitive, versatile, and easy to use. The cell-based assay provides more information than in vitro assays regarding the bioavailability of NOS inhibitors, and it is suitable for high-throughput screening.


Asunto(s)
Calorimetría/métodos , Inhibidores Enzimáticos/química , Óxido Nítrico Sintasa de Tipo I/antagonistas & inhibidores , Amidinas/química , Amidinas/farmacología , Animales , Calcio/metabolismo , Línea Celular , Inhibidores Enzimáticos/farmacología , Etilenodiaminas/metabolismo , Etilenodiaminas/farmacología , Humanos , Iminas/química , Iminas/farmacología , Modelos Biológicos , Óxido Nítrico Sintasa de Tipo I/metabolismo , Nitritos/análisis , Ratas , Sulfanilamidas/metabolismo , Sulfanilamidas/farmacología , Tiofenos/química , Tiofenos/farmacología
20.
Eur J Med Chem ; 44(7): 2877-87, 2009 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-19144449

RESUMEN

A series of new 3-aroylpyrido[1,2-a]pyrimidines were synthesized from aryl methyl ketones in a simple two-step procedure and evaluated as nitric oxide synthases (NOS) inhibitors. In order to perform a structure-activity relationship study, different aroyl groups were introduced in 3-position and methyl groups were introduced at different positions of the pyrimidine heterocycle. Compounds with a biphenyloyl, benzyloxybenzoyl or naphthoyl group displayed the highest inhibitory effects which were further increased by introduction of a methyl group in position 8 of the pyrido[1,2-a]pyrimidine moiety. Some of the compounds exhibited promising inhibitory effects with selectivity toward the purified inducible NOS (iNOS) and were also active against iNOS expressed in stimulated RAW 264.7 cells.


Asunto(s)
Inhibidores Enzimáticos/síntesis química , Inhibidores Enzimáticos/farmacología , Óxido Nítrico Sintasa/antagonistas & inhibidores , Pirimidinas/síntesis química , Pirimidinas/farmacología , Animales , Línea Celular , Evaluación Preclínica de Medicamentos , Inhibidores Enzimáticos/química , Inhibidores Enzimáticos/metabolismo , Etilenodiaminas/metabolismo , Regulación Enzimológica de la Expresión Génica , Hemo/metabolismo , Humanos , Isoenzimas/antagonistas & inhibidores , Isoenzimas/química , Isoenzimas/metabolismo , Macrófagos/efectos de los fármacos , Macrófagos/metabolismo , Ratones , NADP/metabolismo , Óxido Nítrico Sintasa/química , Óxido Nítrico Sintasa/metabolismo , Óxido Nítrico Sintasa de Tipo II/antagonistas & inhibidores , Pirimidinas/química , Pirimidinas/metabolismo , Radiactividad , Ratas , Relación Estructura-Actividad , Especificidad por Sustrato , Sulfanilamidas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...